TY - JOUR
T1 - Depression profile in malignancy patients attending otorhinolaryngology clinic
AU - Khadilkar, Meera Niranjan
AU - Pai, K. Keshava
AU - Rai, Thripthi
AU - Shenoy, Vijendra
AU - Dosemane, Deviprasad
AU - Kabekkodu, Sushmitha
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Purpose: Patients with malignancy quite often suffer from physical as well as psychological symptoms due to the shattering diagnosis, and prolonged, incapacitating management. The frequency of the depressive disorder in malignancy is around 8–40%. The present study aims at analysing the socio-demographic profile and magnitude of depressive disorders in patients with malignancy. Methods: A cross-sectional study was conducted in malignancy patients attending an Ear Nose Throat department using the PHQ-9 questionnaire. Results: Total PHQ-9 score ranged from 0 to 19; the mean score was 8.46. Major depressive disorder was seen in 4 (8%) cases, while other depressive disorder occurred in 22 (44%) cases. Mild severity of symptoms was noted in 15 (30%) of the patients. High statistical significance was noted between PHQ-9 score for MDD and other depressive disorder (p value < 0.001). Conclusion: The profile of depressive disorders in malignancy varies; PHQ-9 can be used as a good tool for early detection.
AB - Purpose: Patients with malignancy quite often suffer from physical as well as psychological symptoms due to the shattering diagnosis, and prolonged, incapacitating management. The frequency of the depressive disorder in malignancy is around 8–40%. The present study aims at analysing the socio-demographic profile and magnitude of depressive disorders in patients with malignancy. Methods: A cross-sectional study was conducted in malignancy patients attending an Ear Nose Throat department using the PHQ-9 questionnaire. Results: Total PHQ-9 score ranged from 0 to 19; the mean score was 8.46. Major depressive disorder was seen in 4 (8%) cases, while other depressive disorder occurred in 22 (44%) cases. Mild severity of symptoms was noted in 15 (30%) of the patients. High statistical significance was noted between PHQ-9 score for MDD and other depressive disorder (p value < 0.001). Conclusion: The profile of depressive disorders in malignancy varies; PHQ-9 can be used as a good tool for early detection.
UR - http://www.scopus.com/inward/record.url?scp=85089486324&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089486324&partnerID=8YFLogxK
U2 - 10.1007/s00405-020-06289-w
DO - 10.1007/s00405-020-06289-w
M3 - Article
C2 - 32804271
AN - SCOPUS:85089486324
SN - 0937-4477
VL - 278
SP - 537
EP - 541
JO - European Archives of Oto-Rhino-Laryngology
JF - European Archives of Oto-Rhino-Laryngology
IS - 2
ER -